Validation of a nomogram in the prediction of local recurrence risks after conserving surgery for Asian women with ductal carcinoma in situ of the breast

Clinical Oncology

Volumn 26, Issue 11, 2014, Pages 684-691

  Wang, F ^a   Li, H ^b   Tan, P H ^b   Chua, E T ^a   Yeo, R M C ^a   Lim, F L W T ^a   Kim, S W ^a   Tan, D Y H ^a   Wong, F Y ^a  

^a DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Breast; DCIS; Nomogram; Prediction; Recurrence

Indexed keywords

ADULT; ARTICLE; ASIAN; BOOTSTRAPPING; BREAST NECROSIS; BREAST TUMOR; CANCER ADJUVANT THERAPY; CANCER CENTER; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL EVALUATION; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; INTRADUCTAL CARCINOMA; IPSILATERAL BREAST TUMOR RECURRENCE; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; MULTIVARIATE ANALYSIS; NOMOGRAM; OVERALL SURVIVAL; PARTIAL MASTECTOMY; PREDICTIVE VALUE; PROPORTIONAL HAZARDS MODEL; RECURRENCE RISK; RISK FACTOR; TREATMENT OUTCOME; ASIA; BREAST NEOPLASMS; CANCER STAGING; CARCINOMA, INTRADUCTAL, NONINFILTRATING; EPIDEMIOLOGY; FOLLOW UP; INCIDENCE; NEOPLASM RECURRENCE, LOCAL; PATHOLOGY; RETROSPECTIVE STUDY; SEGMENTAL MASTECTOMY; VALIDATION STUDY;

ASIA; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NOMOGRAMS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES;

EID: 84908079422     PISSN: 09366555     EISSN: 14332981     Source Type: Journal    
DOI: 10.1016/j.clon.2014.08.004     Document Type: Article

References (42)

1. Lee HP, Chew L, Chow KY, et al. Singapore Cancer Registry interim annual registry report trends in cancer incidence in Singapore 2006-2010. National Registry of Disease Office.
2. Wang S.C. The Singapore National Breast Screening Programme: principles and implementation. Ann Acad Med Singapore 2003, 32:466-476.
3. Wang W.V., Tan S.M., Chow W.L. The impact of mammographic breast cancer screening in Singapore: a comparison between screen-detected and symptomatic women. Asian Pac J Cancer Prev 2011, 12:2735-2740.
4. Chuwa E.W., Yeo A.W., Koong H.N., et al. Early detection of breast cancer through population-based mammographic screening in Asian women: a comparison study between screen-detected and symptomatic breast cancers. Breast J 2009, 15(2):133-139. 10.1111/j.1524-4741.2009.00687.x.
5. Wapnir I.L., Dignam J.J., Fisher B., et al. Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. J Natl Cancer Inst 2011, 103(6):478-488. 10.1093/jnci/djr027.
6. Correa C., McGale P., Taylor C., et al. Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. J Natl Cancer InstMonogr 2010, 2010(41):162-177. Early Breast Cancer Trialists' Collaborative Group (EBCTCG).
7. Julien J.P., Bijker N., Fentiman I.S., et al. Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. Lancet 2000, 355(9203):528-533.
8. Holmberg L., Garmo H., Granstrand B., et al. Absolute risk reductions for local recurrence after postoperative radiotherapy after sector resection for ductal carcinoma in situ of the breast. J Clin Oncol 2008, 26(8):1247-1252. 10.1200/JCO.2007.12.7969.
9. Solin L.J., Fourquet A., Vicini F.A., et al. Long-term outcome after breast-conservation treatment with radiation for mammographically detected ductal carcinoma in situ of the breast. Cancer 2005, 103(6):1137-1146.
10. Chuwa E.W., Tan V.H., Tan P.H., et al. Treatment for ductal carcinoma in situ in an Asian population: outcome and prognostic factors. ANZ J Surg 2008, 78(1-2):42-48. 10.1111/j.1445-2197.2007.04354.x.
11. Pinder S.E., Duggan C., Ellis I.O., et al. A new pathological system for grading DCIS with improved prediction for local recurrence: results from the UKCCCR/ANZ DCIS trial. Br J Can 2010, 103:94-100.
12. Silverstein M.J., Lagios M.D. Choosing treatment for patients with ductal carcinoma in situ: fine tuning the University of South Carolina/Van Nuys Prognostic Index. J Natl Cancer Inst Monogr 2010, 41:193-196.
13. Rudloff U., Jacks L.M., Goldberg J.I., et al. Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ. J Clin Oncol 2010, 28(23):3762-3769. 10.1200/JCO.2009.26.8847.
14. Yi M., Meric-Bernstam F., Kuerer H.M., et al. Evaluation of a breast cancer nomogram for predicting risk of ipsilateral breast tumor recurrences in patients with ductal carcinoma in situ after local excision. J Clin Oncol 2012, 30(6):600-607. 10.1200/JCO.2011.36.4976.
15. Collins L.C., Achacoso N., Sharafali Z., et al. Predictors of local recurrence (LR) in patients with ductal carcinoma in situ (DCIS) treated by breast conserving therapy (BCT): value of the Memorial Sloan-Kettering (MSK) nomogram. Mod Pathol 2012, [abstract].
16. Sweldens C., Peeters S., Limbergen E., et al. Local relapse after breast-conserving therapy for ductal carcinoma in situ: a European single-center experience and external validation of the Memorial Sloan-Kettering Cancer Center DCIS nomogram. Cancer J 2014, 20(1):1-7.
17. Leong S.P.L., Shen Z.Z., Liu T.J., et al. Is breast cancer the same disease in Asian and Western countries?. World J Surg 2010, 34(10):2308-2324. 10.1007/s00268-010-0683-1.
18. Tam C.Y., Martin L.J., Hislop G., et al. Risk factors for breast cancer in postmenopausal Caucasian and Chinese-Canadian women. Breast Cancer Res 2010, 12(1):R2. 10.1186/bcr2465.
19. Farooq S., Coleman M.P. Breast cancer survival in South Asian women in England and Wales. J Epidemiol Commun Health 2005, 59:402-406. 10.1136/jech.2004.030965.
20. Tan M.H., Li H., Choong C.V., et al. The Karakiewicz nomogram is the most useful clinical predictor for survival outcomes in patients with localized renal cell carcinoma. Cancer 2011, 117(23):5314-5324. 10.1002/cncr.26193.
21. Tan P.H., Thike A.A., Tan W.J., et al. Predicting clinical behaviour of breast phyllodes tumour: a nomogram based on histological criteria and surgical margins. J Clin Pathol 2012, 65(1):69-76. 10.1136/jclinpath-2011-200368.
22. Akaike H. A new look at the statistical model identification. IEEE Trans Auto Control 2003, 19(6):716-723.
23. Harrell F.E., Lee K.L., Mark D.B. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996, 15:361-387.
24. Harrell F.E. Regression modeling strategies with application to linear models, logistic regression, and survival analysis 2001, Springer, New York.
25. Vickers A.J., Cronin A.M., Elkin E.B., et al. Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers. BMC Med Inform Decision Making 2008, 8:53. 10.1186/1472-6947-8-53.
26. MacAusland S.G., Hepel J.T., Chong F.K., et al. An attempt to independently verify the utility of the Van Nuys Prognostic Index for ductal carcinoma in situ. Cancer 2007, 110(12):2648-2653.
27. Boland G.P., Chan K.C., Knox W.F., et al. Value of the Van Nuys Prognostic Index in prediction of recurrence of ductal carcinoma in situ after breast-conserving surgery. Br J Surg 2003, 90(4):426-432.
28. Solin L.J., Gray R., Baehner F.L., et al. A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast. J Natl Cancer Inst 2013, 105(10):701-710. 10.1093/jnci/djt067.
29. Goldstein L.J., Gray R., Badve S., et al. Prognostic utility of the 21-gene assay in hormone receptor-positive operable breast cancer compared with classical clinicopathologic features. J Clin Oncol 2008, 26:4063-4071.
30. ®) in lymph node-negative/positive, hormone receptor-positive early-stage breast cancer based on Japanese validation study (JBCRG-TR03). Breast Cancer Res Treat 2011, 127:739-749.
31. Yau T.K., Chan K., Chan M., et al. Wide local excision and radiotherapy for the treatment of ductal carcinoma in situ of the breast: the Hong Kong experience. Clin Oncol 2006, 18:447-452.
32. Long J., Shu X., Cai Q., et al. Evaluation of breast cancer susceptibility loci in Chinese women. Cancer Epidemiol Biomarkers Prev 2010, 19:2357. 10.1158/1055-9965.EPI-10-0054.
33. Cai Q., Long J., Lu W., et al. Genome-wide association study identifies breast cancer risk variant at 10q21.2: results from the Asia Breast Cancer Consortium. Hum Mol Genet 2011, 20:4991-4999. 10.1093/hmg/ddr405.
34. Wong P., Lambert C., Agnihotram R.V., et al. Ductal carcinoma in situ - the influence of the radiotherapy boost on local control. Int J Radiat Oncol Biol Phys 2012, 82(2):e153-158. 10.1016/j.ijrobp.2011.03.045.
35. Omlin A., Amichetti M., Azria D., et al. Boost radiotherapy in young women with ductal carcinoma in situ: a multicentre, retrospective study of the Rare Cancer Network. Lancet Oncol 2006, 7(8):652-656.
36. Fisher B., Dignam J., Wolmark N., et al. Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial. Lancet 1999, 353(9169):1993-2000.
37. Houghton J., George W.D., Cuzick J., et al. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial. Lancet 2003, 362(9378):95-102.
38. Allred D.C., Anderson S.J., Paik S., et al. Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24. J Clin Oncol 2012, 30(12):1268-1273.
39. Roupret M., Hupertan V., Seisen T., et al. Prediction of cancer specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: development of an optimized postoperative nomogram using decision curve analysis. J Urol 2013, 189:1662-1669. 10.1016/j.juro.2012.10.057.
40. Hughes L.L., Wang M., Page D.L., et al. Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group. J Clin Oncol 2009, 27(32):5319-5324. 10.1200/JCO.2009.21.8560.
41. Wong F.Y., Wang F.Q., Chen J.J., et al. Outcomes of low-risk ductal carcinoma in situ in Southeast Asian women treated with breast conservation therapy. Int J Radiat Oncol Biol Phys 2014, 88(5):998-1003.
42. Motwani S.B., Goyal S., Moran M.S., et al. Ductal carcinoma in situ treated with breast-conserving surgery and radiotherapy: a comparison with ECOG study 5194. Cancer 2011, 117(6):1156-1162.